Zobrazeno 1 - 10
of 104
pro vyhledávání: '"papillary renal carcinoma"'
Autor:
Niloofar Khoshdel Rad, Maryam Vahidyeganeh, Mahsa Mohammadi, Anastasia Shpichka, Peter Timashev, Nikoo Hossein-Khannazer, Massoud Vosough
Publikováno v:
International Journal of Translational Medicine, Vol 2, Iss 4, Pp 555-573 (2022)
Non-clear cell renal cell carcinomas (nccRCC) are a diverse group of kidney cancers with histopathologically and genetically heterogeneous features. About 25% of renal cell carcinomas (RCCs) are nccRCC types. The management and treatment of nccRCCs a
Externí odkaz:
https://doaj.org/article/24080c735b0046d6a7e6e6e4022496bd
Autor:
Ariane Perry, Claire Douillard, Frederic Jonca, Francois Glowacki, Xavier Leroy, Paul Caveriviere, Aurélie Hubert, Philippe Labrune
Publikováno v:
JIMD Reports, Vol 52, Iss 1, Pp 17-22 (2020)
Abstract Glycogen storage disease type Ia (GSD Ia) is a rare metabolic disease due to glucose‐6‐phosphatase deficiency. Chronic kidney disease is a frequent complication that may manifest itself by glomerular lesions and tubular dysfunction from
Externí odkaz:
https://doaj.org/article/3826cc02f85640a09008e0511b007ad8
Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
Autor:
Josiah An, Vignesh T. Packiam, Adithya Chennamadhavuni, Jordan Richards, Jayanshu Jain, Sarah L. Mott, Rohan Garje
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
BackgroundNon-clear cell renal cell carcinoma (ccRCC) includes histologically and molecularly distinct subtypes such as papillary, chromophobe, collecting duct, and sarcomatoid RCC, with an incidence ranging from 20% to 25%. Oncologic outcomes and th
Externí odkaz:
https://doaj.org/article/1dde99dfdb844dbbb1d343f4e93e3575
Publikováno v:
Cells, Vol 11, Iss 10, p 1658 (2022)
Papillary renal cell carcinoma (pRCC) represents the second most common subtype of renal cell carcinoma, following clear cell carcinoma and accounting for 10–15% of cases. For around 20 years, pRCCs have been classified according to their mere hist
Externí odkaz:
https://doaj.org/article/942cf336a39c4620bb02dbfe6f59a6a2
Publikováno v:
Frontiers in Genetics, Vol 11 (2020)
Papillary renal carcinoma (PRCC) is one of the important subtypes of kidney cancer, with a high degree of heterogeneity. At present, there is still a lack of robust and accurate biomarkers for the diagnosis, prognosis and treatment selection of PRCC.
Externí odkaz:
https://doaj.org/article/6600e7d850b646b7af7be6864258521a
Publikováno v:
Case Reports in Oncology, Vol 5, Iss 2, Pp 229-232 (2012)
Cancer of unknown primary (CUP) is a clinical syndrome representing many types of cancers and diagnoses are typically made after review of clinical presentation, pathology (including immunohistochemical staining) and imaging studies. Treatment with s
Externí odkaz:
https://doaj.org/article/4d1329ef72a14fde8235922d5da72e0c
Autor:
Claire Douillard, Paul Caveriviere, Aurélie Hubert, Ariane Perry, Philippe Labrune, Xavier Leroy, François Glowacki, Frederic Jonca
Publikováno v:
JIMD Reports
JIMD Reports, Vol 52, Iss 1, Pp 17-22 (2020)
JIMD Reports, Vol 52, Iss 1, Pp 17-22 (2020)
Glycogen storage disease type Ia (GSD Ia) is a rare metabolic disease due to glucose‐6‐phosphatase deficiency. Chronic kidney disease is a frequent complication that may manifest itself by glomerular lesions and tubular dysfunction from the secon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1ad7c4637f5da952fe0d7b46b0b22cd
http://europepmc.org/articles/PMC7052693
http://europepmc.org/articles/PMC7052693
Publikováno v:
Kidney Cancer
Papillary renal cell carcinoma (PRCC) is a subtype of renal cell carcinoma (RCC) accounting for approximately 15–20% of cases and further divided into Type 1 and Type 2. Type 1 PRCC tends to have more alterations in the MET tyrosine kinase receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e4f7c6d427e2dd43748fe2e7fac7a6
https://doi.org/10.3233/kca-190058
https://doi.org/10.3233/kca-190058
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Genetics
Frontiers in Genetics, Vol 11 (2020)
Frontiers in Genetics, Vol 11 (2020)
Background: Papillary renal carcinoma (PRCC) is one of the important subtypes of kidney cancer, with a high degree of heterogeneity. At present, there is still a lack of robust and accurate biomarkers for the diagnosis, prognosis and treatment select
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7421e163d209f3d69343fda24e6311b8
https://doi.org/10.21203/rs.3.rs-29603/v1
https://doi.org/10.21203/rs.3.rs-29603/v1
